Early DischargeTelemedicineVirtual ClinicHospital at HomeFeasibility Studies
Investigational drug(s) / intervention(s)
Virtual Ward
Virtual Ward: Hospital-level care at home using remote vital sign monitoring, digital anamnesis via the Digizorg app, and integration with the Electronic Medical Record (HiX), managed by Virtual Ward staff following predefined care pathways.
Study summary
This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adult patients (≥18 years old).
* Currently hospitalized and eligible for early discharge according to clinical judgment.
* Ability to provide written informed consent.
* Access to a smartphone or tablet with internet connection.
* Patient is capable of using the Digizorg app or has support from a caregiver who can assist.
* Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available).
* Enrollment in one of the predefined Virtual Ward care pathways
Exclusion Criteria:
* Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home.
* Patients who are hemodynamically unstable or require oxygen therapy \>5 liters/minute at the time of discharge.
* Patients unable or unwilling to comply with home monitoring procedures.
* Patients with significant cognitive impairment without adequate caregiver support.
* Patients with a life expectancy less than 30 days, as assessed by the treating physician.
* Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol.
* Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.
Primary outcome measure(s)
Number of Participants Successfully Transferred to the Virtual Ward After Providing Informed Consent — From enrollment to transfer to Virtual Ward (during hospitalization, up to 7 days) Successful transfer is defined as discharge from hospital to the Virtual Ward with start of home monitoring according to care pathways. Threshold for feasibility is ≥30%.
Trial sites (1)
Facility
City
Region
Status
Erasmus Medical Center
Rotterdam
Netherlands
Recruiting
More Erasmus Medical Center trials in the Netherlands
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
